A Study of GZR18 Injection in Chinese Obese/Overweight Patients
Status:
COMPLETED
Trial end date:
2023-10-22
Target enrollment:
Participant gender:
Summary
The study was a multicenter, randomized, double-blind, placebo-controlled phase Ib/IIa clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of GZR18 injection in Chinese adult obese/overweight patients. This study is divided into Part A and Part B, which are to be conducted simultaneously.